Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H van der Meide

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Scandinavian Journal of Immunology|July 1, 1988
Modulation of major histocompatibility complex (MHC) expression by interferons and microbial agents. Independent regulation of MHC class II expression and induction of tumoricidal activity in bone marrow-derived mononuclear phagocytesR Keller, P Joller, R Keist, et al.
Acta Neurologica Scandinavica|September 1, 1989
In vivo treatment of rats with monoclonal antibodies against gamma interferon: effects on experimental allergic neuritisK Strigård, R Holmdahl, P H van der Meide, et al.
The Journal of Experimental Medicine|November 1, 1986
Antagonistic effects of gamma interferon and steroids on tissue antigenicityD Leszczynski, B Ferry, H Schellekens, et al.
Anticancer Research|May 1, 1996
Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gammaA J Lumsden, J P Codde, P H Van der Meide, et al.
In Vivo (Athens, Greece)|September 1, 1992
Improved efficacy of doxorubicin by simultaneous treatment with interferon-gamma and interleukin-2A J Lumsden, J P Codde, B N Gray, et al.
International Journal of Cancer|October 15, 1990
Mechanisms of macrophage-mediated tumor cell killing: a comparative analysis of the roles of reactive nitrogen intermediates and tumor necrosis factorR Keller, R Keist, A Wechsler, et al.
Anticancer Research|September 1, 1992
Prevention of myelosuppression does not improve the therapeutic efficacy of chemo-immunotherapyA J Lumsden, J P Codde, B N Gray, et al.
Nature|October 9, 1986
The hepatitis delta (delta) virus possesses a circular RNAA Kos, R Dijkema, A C Arnberg, et al.
Journal of Immunoassay|January 1, 1991
Complement-mediated inactivation of interferon-gamma in ELISA systemsP H van der Meide, M C de Labie, J A Wubben, et al.
European Journal of Immunology|October 1, 1991
Bidirectional activating signals between Trypanosoma brucei and CD8+ T cells: a trypanosome-released factor triggers interferon-gamma production that stimulates parasite growthT Olsson, M Bakhiet, C Edlund, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Scandinavian Journal of Immunology|July 1, 1988
Modulation of major histocompatibility complex (MHC) expression by interferons and microbial agents. Independent regulation of MHC class II expression and induction of tumoricidal activity in bone marrow-derived mononuclear phagocytesR Keller, P Joller, R Keist, et al.
Acta Neurologica Scandinavica|September 1, 1989
In vivo treatment of rats with monoclonal antibodies against gamma interferon: effects on experimental allergic neuritisK Strigård, R Holmdahl, P H van der Meide, et al.
The Journal of Experimental Medicine|November 1, 1986
Antagonistic effects of gamma interferon and steroids on tissue antigenicityD Leszczynski, B Ferry, H Schellekens, et al.
Anticancer Research|May 1, 1996
Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gammaA J Lumsden, J P Codde, P H Van der Meide, et al.
In Vivo (Athens, Greece)|September 1, 1992
Improved efficacy of doxorubicin by simultaneous treatment with interferon-gamma and interleukin-2A J Lumsden, J P Codde, B N Gray, et al.
International Journal of Cancer|October 15, 1990
Mechanisms of macrophage-mediated tumor cell killing: a comparative analysis of the roles of reactive nitrogen intermediates and tumor necrosis factorR Keller, R Keist, A Wechsler, et al.
Anticancer Research|September 1, 1992
Prevention of myelosuppression does not improve the therapeutic efficacy of chemo-immunotherapyA J Lumsden, J P Codde, B N Gray, et al.
Nature|October 9, 1986
The hepatitis delta (delta) virus possesses a circular RNAA Kos, R Dijkema, A C Arnberg, et al.
Journal of Immunoassay|January 1, 1991
Complement-mediated inactivation of interferon-gamma in ELISA systemsP H van der Meide, M C de Labie, J A Wubben, et al.
European Journal of Immunology|October 1, 1991
Bidirectional activating signals between Trypanosoma brucei and CD8+ T cells: a trypanosome-released factor triggers interferon-gamma production that stimulates parasite growthT Olsson, M Bakhiet, C Edlund, et al.
Pageof 15